Danaher Net Change in Property, Plant, and Equipment 2010-2024 | DHR
Danaher annual/quarterly net change in property, plant, and equipment history and growth rate from 2010 to 2024. Net change in property, plant, and equipment can be defined as the overall change in capital expenditures and sales of plant, property and equipment. This field is used if a company does not report separately sales and purchases of plant, property and equipment or is calculated as the sum of purchases and sales of PP&E
- Danaher net change in property, plant, and equipment for the quarter ending September 30, 2024 was $-0.864B, a 8.38% decline year-over-year.
- Danaher net change in property, plant, and equipment for the twelve months ending September 30, 2024 was $-3.103B, a 6.6% increase year-over-year.
- Danaher annual net change in property, plant, and equipment for 2023 was $-1.371B, a 23.62% increase from 2022.
- Danaher annual net change in property, plant, and equipment for 2022 was $-1.109B, a 9.62% decline from 2021.
- Danaher annual net change in property, plant, and equipment for 2021 was $-1.227B, a 55.51% increase from 2020.
Danaher Annual Net Change in Property, Plant, and Equipment (Millions of US $) |
2023 |
$-1,371 |
2022 |
$-1,109 |
2021 |
$-1,227 |
2020 |
$-789 |
2019 |
$-623 |
2018 |
$-578 |
2017 |
$-538 |
2016 |
$-580 |
2015 |
$-453 |
2014 |
$-465 |
2013 |
$-538 |
2012 |
$-458 |
2011 |
$-335 |
2010 |
$-190 |
2009 |
$-170 |
Sector |
Industry |
Market Cap |
Revenue |
Multi-Sector Conglomerates |
Diversified Operations |
$165.986B |
$23.890B |
Danaher Corporation is a global conglomerate that designs, manufactures and markets diverse lines of professional, industrial, commercial and consumer products. The company's segmental details are provided below: Life Sciences segment offers a broad range of research tools used to analyze a range of critical areas including genes, proteins, metabolites and cells to understand the causes of diseases, identify new therapies, and test new drugs and vaccines. Range of industries served includes biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial. Diagnostics segment offers analytical instruments, reagents, consumables, software and services that are deployed in reference laboratories, hospitals, physicians' offices and other critical care settings. It helps to diagnose diseases and take suitable treatment decisions. Environmental & Applied Solutions segment offers products and services that help keep food and water supplies safe globally.
|